Andere talen Chengdu Olymvax Biopharmaceuticals Inc.

Aandelen

688319

CNE1000051H8

slotkoers Shanghai S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
9,1 ^CNY	+1,79%		+3,29%	-42,41%

25/04	Chengdu Olymvax Biopharmaceuticals Inc. meldt winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
27/02	Chengdu Olymvax Biopharmaceuticals Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Olymvax Biopharmaceuticals Withdraws Application for Combined Influenza Vaccine	02/02
Olymvax Biopharmaceuticals Grants Keyuan Xinhai Marketing Rights for Meningococcal Vaccines	12/12
Olymvax Biopharmaceuticals to Push Through Phase III Trial Into Recombinant Staphylococcus Aureus Vaccine	21/11
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
Chengdu Olymvax Biopharmaceuticals Inc.(XSSC:688319) added to S&P Global BMI Index	18-09-23
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	17-08-23
Chinese healthcare stocks hit by stepped up anti-graft crackdown	09-08-23
Olymvax Biopharma Gets Nod to Amend Packaging of Adsorbed Tetanus Vaccine	12-07-23
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	25-04-23
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27-02-23
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	28-10-22
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	17-08-22
Chengdu Olymvax Biopharmaceuticals Inc.(SHSE:688319) added to Shanghai Stock Exchange A Share Index	08-06-22
Chengdu Olymvax Biopharmaceuticals Inc.(SHSE:688319) added to Shanghai Stock Exchange Composite Index	08-06-22
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	28-04-22
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-22
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021	29-10-21
Chengdu Olymvax Biopharmaceuticals Inc. has completed an IPO in the amount of CNY 400.4 million.	31-05-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Chengdu Olymvax Biopharmaceuticals Inc.

Aandelen

688319

CNE1000051H8

Andere talen

Filters